MitoQ and ischemic conditioning to improve vascular health after stroke
Official title: MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes (MITO Study)
Run by Medical College of Wisconsin · NCT06930638 · Data updated 2026-11-12
This project will test whether a brief session of limb ischemic conditioning or taking the antioxidant MitoQ can improve blood vessel function in adults who had a stroke at least six months ago.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Medical College of Wisconsin Academic / other |
| Locations | 1 site (Milwaukee, Wisconsin) |
| Status | Recruiting |
| Started | July 22, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT06930638 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are English-speaking adults aged 18–85 who had a cortical or subcortical stroke at least six months ago with residual hemiparesis and who can follow commands and stand without physical assistance.
✕Probably not a fit
People with contraindications to limb compression, peripheral vascular disease, recent myocardial infarction or arrhythmia, uncontrolled high blood pressure, significant comorbid neurological disorders, recent severe COVID-19 hospitalization, or who are pregnant or breastfeeding are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this Phase 2 interventional trial, adults with chronic cortical or subcortical stroke and residual hemiparesis will receive a single bout of ischemic conditioning or oral MitoQ supplementation to examine effects on vascular function. Researchers will measure outcomes such as flow-mediated dilation, microvascular blood flow, and muscle activity before and after the interventions. The protocol targets safety and short-term physiological changes that might underlie improved exercise tolerance and lower secondary cardiovascular risk. The study is conducted at the Medical College of Wisconsin and focuses on objective vascular measures rather than clinical recovery endpoints.
Why it matters
Potential benefit: If successful, these interventions could improve vascular function and muscle activity after stroke, which may reduce secondary cardiovascular risk and improve exercise tolerance.
How similar studies have gone: Preliminary data and small studies suggest single bouts of ischemic conditioning or MitoQ may improve vascular function, but larger confirmatory trials are still needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 - 85 years of age * Cortical or sub-cortical stroke ≥ 6 months ago with residual hemiparesis * Able to give informed consent and follow 2-step command. * English Speaking Exclusion Criteria: * Unable to stand from chair without physical assistance from another person (able to use assistive device). * History of blood clots in the extremities or any condition in which compression of the thigh or transient ischemia is contraindicated (i.e., wounds in the leg). * Chronic lasting symptoms (\> 6 months) of severe COVID-19 (i.e., hospitalization) * History of head trauma or concussion within the past 6 months * Comorbid neurological disorder * Peripheral vascular disease * Myocardial infarction or arrhythmia in the previous year * Resting SBP ≥180 mmHg or DBP ≥ 100 mmHg * Pregnant or breastfeeding. * Other significant medical condition likely to influence study or jeopardize safety as assessed by the Primary Investigator
Where it's running
-
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Matthew Durand, PhD — Medical College of Wisconsin
- Study coordinator: Jennifer Nguyen
- Email: jnguyen@mcw.edu
- Phone: 414-955-5713
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.